Age, gender, and etiology significantly influence prognosis together with the recently validated simplified PAH risk table but don’t significantly influence the response to PAH-specific treatment.
Current guidelines to diagnosis pulmonary embolism in pregnant patients offer conflicting recommendations.
Individuals with pulmonary hypertension experienced lower primary graft dysfunction following heart-lung transplantation compared with double-lung transplantation.
The REVEAL 2.0 three category score was better at discriminating risks in patients with pulmonary arterial hypertension than similar tools such as COMPERA and FPHR.
Investigators sought to differentiate cardiac exercise responses in patients with pulmonary arterial hypertension stratified according to established measurements of disease severity.
Investigators assessed the prevalence of perioperative adverse cardiovascular events after noncardiac surgery in patients with and without pulmonary hypertension.
Lesion morphology was the sole predictor of balloon pulmonary angioplasty-related complications, whereas hemodynamic parameters were not associated with the frequency of complications.
There may be an additive benefit to adding neprilysin inhibitors to PDE5 therapy in patients with pulmonary arterial hypertension.
Tofacitinib dosed at 10 mg twice daily was associated with an increased risk of pulmonary embolism and overall mortality in patients with rheumatoid arthritis.
Researchers examined the effects of acutely inhaled iloprost on right ventricular physiology.
